NCT00390052 2013-12-16
3-AP in Treating Patients With Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
Clinical Trials
6 trialsPhase 1 × Unspecified Adult Solid Tumor, Protocol Specific × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT00004213 2013-07-18
3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00006218 2013-07-18
3-AP in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00024323 2013-07-18
Combination Chemotherapy in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00079014 2013-05-16
3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00084877 2013-05-16
Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed